scholarly journals Improving guideline adherence for cardiac rehabilitation in the Netherlands

2011 ◽  
Vol 19 (6) ◽  
pp. 285-289 ◽  
Author(s):  
H. M. C. Kemps ◽  
M. M. van Engen-Verheul ◽  
R. A. Kraaijenhagen ◽  
R. Goud ◽  
I. M. Hellemans ◽  
...  
2016 ◽  
Vol 25 (11) ◽  
pp. 1161-1170 ◽  
Author(s):  
Ymkje Anna de Vries ◽  
Peter de Jonge ◽  
Luuk Kalverdijk ◽  
Jens H. J. Bos ◽  
Catharina C. M. Schuiling-Veninga ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Lotte Heutinck ◽  
Maaike van Gameren ◽  
Jan J.G.M. Verschuuren ◽  
Alexander C.H. Geurts ◽  
Merel Jansen ◽  
...  

Background: In order to successfully implement the international clinical care guidelines for Duchenne muscular dystrophy (DMD) in the Netherlands, it is essential to know what barriers are experienced by healthcare practitioners regarding guideline adherence and organization of care. In the Netherlands, academic medical centers provide follow up visits and work together with peripheral hospitals, rehabilitation centers, centers for home ventilation and primary care centers for treatment. Objective: To investigate perceived barriers to international clinical DMD guideline adherence and identify potential areas of improvement for implementation in the Dutch ‘shared care’ organization. Methods: Semi-structured in-depth interviews with healthcare practitioners of academic medical hospitals and questionnaires for healthcare practitioners of rehabilitation centers, based on the framework of Cabana. Results: The analyses identified 4 barriers for non-adherence to the DMD guideline: (i) lack of familiarity/awareness, (ii) lack of agreement with specific guideline, (iii) lack of outcome expectancy, (iv) external barriers. Conclusions: A heterogeneous set of barriers is present. Therefore, a multifaceted intervention strategy is proposed to overcome these barriers, including a clear division of roles, allowing for local (Dutch) adaptations per specialism by local consensus groups, and the facilitation of easy communication with experts/opinion leaders as well as between care professionals.


2020 ◽  
Vol 3 (7) ◽  
pp. e2011686
Author(s):  
Thijs M. H. Eijsvogels ◽  
Martijn F. H. Maessen ◽  
Esmée A. Bakker ◽  
Esther P. Meindersma ◽  
Niels van Gorp ◽  
...  

Author(s):  
Ö. Erküner ◽  
M. van Eck ◽  
O. Xhaet ◽  
H. Verheij ◽  
J. Neefs ◽  
...  

Abstract Background Contemporary data regarding the characteristics, treatment and outcomes of patients with atrial fibrillation (AF) are needed. We aimed to assess these data and guideline adherence in the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) long-term general registry. Methods We analysed 967 patients from the EORP-AF long-term general registry included in the Netherlands and Belgium from 2013 to 2016. Baseline and 1‑year follow-up data were gathered. Results At baseline, 887 patients (92%) received anticoagulant treatment. In 88 (10%) of these patients, no indication for chronic anticoagulant treatment was present. A rhythm intervention was performed or planned in 52 of these patients, meaning that the remaining 36 (41%) were anticoagulated without indication. Forty patients were not anticoagulated, even though they had an indication for chronic anticoagulation. Additionally, 63 of the 371 patients (17%) treated with a non-vitamin K antagonist oral anticoagulant (NOAC) were incorrectly dosed. In total, 50 patients (5%) were overtreated and 89 patients (9%) were undertreated. However, the occurrence of major adverse cardiac and cerebrovascular events (MACCE) was still low with 4.2% (37 patients). Conclusions Overtreatment and undertreatment with anticoagulants are still observable in 14% of this contemporary, West-European AF population. Still, MACCE occurred in only 4% of the patients after 1 year of follow-up.


Sign in / Sign up

Export Citation Format

Share Document